HOME     SCHEDULE     AUTHOR INDEX     SUBJECT INDEX         

PARENT SESSION
1:45 PM to 3:30 PM
Sunday, April 21, 2002
NAHS Mini-Symposium 3
NAHS Thermochemotherapy

Room: Nevada 1-2
Chair: Bull, Joan226431 Fannin St., Medical Onc MSB 5.280, Houston, TX, Co-Chair: Park, John33Box 1710, San Francisco, CA
Speakers: Repasky, Elizabeth4; Goldberg, S. Nahum5; Poulson, Jean6; Park, John7; Bull, Joan84Elm & Carlton Streets, Buffalo, NY5330 Brookline Ave., Boston, MA6Box 3455, Durham, NC7Box 1710, San Francisco, CA86431 Fannin St., Medical Onc MSB 5.280, Houson, TX

(MS03-) Thermochemotherapy.

FULL ABSTRACT

(MS03-1) Mild (fever-range) whole body hyperthermia can selectively increase tumor vascular volume and vessel permeability and can increase the delivery and anti-tumor effectiveness of DOXIL (liposome encapsulated doxorubicin).
Repasky, Elizabeth*,1, Molnar, Merced1, Hylander, Bonnie1, Xu, Yan1, Mazurchuk, Richard1, Evans, Sharon1, Kraybill, William1, 1 Depts of Immunology, Biophysics and Surgery, Buffalo, NY
FULL ABSTRACT

(MS03-2) Radiofrequency Tumor Ablation Combined with Liposomal Doxorubicin.
Goldberg, S. Nahum*,1, Ahmed, Muneeb1, 1 Department of Radiology, Boston, MA
FULL ABSTRACT

(MS03-3) Thermosensitive liposomal doxorubicin combined with local hyperthermia in dogs with spontaneous tumors.
Poulson, J.*,1, Hauck, M.2, LaRue, S.3, Thrall, D.2, Dewhirst, M.1, 1 Duke University Medical Center, Durham, NC2 North Carolina State University, Raleigh, NC3 Colorado State University, Fort Collins, CO
FULL ABSTRACT

(MS03-4) Hyperthermia Significantly Enhances Drug Delivery and Efficacy of Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer of the Chest Wall: A Phase I/II Study .
Park, John*,1, Stauffer, Paul1, Diederich, Chris1, Seo, Teresa1, Kirpotin, Dmitri1, Rugo, Hope1, Sneed, Penny1, 1 UCSF Comprehensive Cancer Center, San Francisco, CA
FULL ABSTRACT

(MS03-5) A Phase I-II clinical trial of fever-range whole-body hyperthermia combined with liposomal doxorubicin (Doxil), 5-fluorouracil (5FU), & metronomic interferon- (IFN-): An interim report.
Bull, Joan*,1, Scott, Glenna1, Strebel, Frederick1, Koch, Steven2, 1 Division of Oncology, Houston, TX2 Department of Anesthesia & Critical Care, Houston, TX
FULL ABSTRACT